Vitruvian Partners’s WalkMe Ltd. Ordinary Shares WKME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,921,122
Closed -$82.7M 8
2024
Q2
$82.7M Hold
5,921,122
24.28% 2
2024
Q1
$50.9M Hold
5,921,122
16.14% 3
2023
Q4
$63.2M Hold
5,921,122
16.06% 3
2023
Q3
$56.1M Hold
5,921,122
15.92% 3
2023
Q2
$56.8M Hold
5,921,122
11.57% 2
2023
Q1
$63M Hold
5,921,122
13.46% 2
2022
Q4
$66.2M Hold
5,921,122
13.94% 2
2022
Q3
$50.3M Hold
5,921,122
8.98% 3
2022
Q2
$60M Hold
5,921,122
10.17% 3
2022
Q1
$89.3M Buy
5,921,122
+339,296
+6% +$5.33M 9.48% 3
2021
Q4
$110M Buy
5,581,826
+1,028,465
+23% +$23.1M 5.7% 4
2021
Q3
$135M Buy
4,553,361
+180,665
+4% +$5.15M 5.65% 4
2021
Q2
$128M Buy
+4,372,696
New +$130M 5.22% 4

Other funds holding WKME

Vitruvian Partners's WKME Position: Q3 2024 in Review

Vitruvian Partners sold out of WalkMe Ltd. Ordinary Shares (WKME) in Q3 2024, closing a stake of 5,921,122 shares — an estimated $82.7M sold.

Vitruvian Partners first reported a position in WKME in Q2 2021 and held it in 13 quarters. The position peaked at $135M in Q3 2021. 5 funds tracked by Wall St. Rank hold WKME as of Q3 2024.

  • Vitruvian Partners reported no remaining WalkMe Ltd. Ordinary Shares position as of Q3 2024 after selling out during the quarter.
  • Vitruvian Partners sold 5,921,122 WalkMe Ltd. Ordinary Shares shares in Q3 2024, an estimated $82.7M.
  • Vitruvian Partners first reported a position in WalkMe Ltd. Ordinary Shares in Q2 2021 and held it in 13 quarters.
  • Vitruvian Partners's WalkMe Ltd. Ordinary Shares position peaked at $135M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held WalkMe Ltd. Ordinary Shares as of Q3 2024.

Based on Vitruvian Partners's 13F filing for Q3 2024, filed 12 Nov 2024.